Founder, Chairman, and CEO, NeuroVigil, Age: 33
Advertisement
The Scientist
Most Recent
$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.
A Chinese biotech company is angling to buy California-based Complete Genomics, but federal regulators are expressing security concerns and may scuttle the deal.
Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.
After two headline successes, companies rush to develop “smart bomb” cancer drugs.
A large Chinese sequencing center’s purchase of Complete Genomics, a California-based DNA services company, ensures the valued technology will remain on the market.
Many vaccines are on the market for various serogroups of meningococcal disease, but a solution to provide broad protection against MenB remains elusive.
Two lawsuits against prominent researcher Craig Thompson for allegedly failing to share intellectual property with his institution lead to a licensing agreement on cancer diagnostics.
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
Simply disclosing conflicts of interest is not enough.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
